EFPIA - NEWSLETTER

EFPIA Newsletter 19 December 2019

HTA: Europe cannot afford an inefficient system

Jean-Christophe Tellier, President of EFPIA and CEO of UCB, looks at the Commission Proposal for a European Regulation on Health Technology Assessment (read here).

Blogs

18 December 2019 A European Cancer Plan – For better, more equal access to cancer care

In a joint effort, ECCO, ECPC and EFPIA have recently put the European Cancer Plan on the agenda of a session of the...

Events

20 DEC 2019

France - A New Method, New Framework, and New Roadmap for Improved Patient Access... Webinar

Discussion on the current access challenges to access to new, innovative oncology treatments in Europe

Learn more →

08 JAN 2020

EU Health Coalition New Year's Reception Brussels

Kindly hosted by Tiemo Wölken, S&D-MEP

Learn more →

15 JAN 2020

Save the Date | Joint EFGCP-EFPIA multi-stakeholder discussion Crowne Plaza Le Palace, Brussels

Roadmap Initiative to Good Lay Summary Practices

Learn more →

21 JAN 2020

Seasonal influenza vaccination: Progressing towards the EU’s 75% target Brussels

Save the Date!

Learn more →

What we are reading

A modern approach to Health Technology Assessment 17 December 2019 (The Parliament Magazine)

The EU Health Coalition highlights the need for concrete measures for better health for people... 13 December 2019 (EU Health Coalition)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶